These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3622542)

  • 1. Electrophysiologic effects and pharmacokinetics of intravenous penticainide (CM 7857).
    Aliot E; Munoz A; Khalife K; Necciari J; Gagnol JP; Gilgenkrantz JM
    Eur Heart J; 1987 Jun; 8(6):618-23. PubMed ID: 3622542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V; Mewis C; Mayer F; Seipel L
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of penticainide in the anaesthetized dog.
    Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
    Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.
    Waleffe A; Dufour A; Aymard MF; Kulbertus H
    Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological studies of penticainide (CM 7857), a new antiarrhythmic agent, in mammalian myocardium.
    Gautier P; Guiraudou P; Pezziardi F; Bertrand JP; Gagnol JP
    J Cardiovasc Pharmacol; 1987 May; 9(5):601-10. PubMed ID: 2439843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of penticainide (CM 7857), a novel class I antiarrhythmic drug--comparison with disopyramide.
    Pfisterer M; Munoz A; Burkart F
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):247-51. PubMed ID: 2459557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of penticainide (CM 7857) in isolated human atrial and ventricular fibers.
    Gautier P; Escande D; Bertrand JP; Seguin J; Guiraudou P
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):328-35. PubMed ID: 2468966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic and electrophysiological effects of amiodarone, lignocaine, and penticainide in anaesthetised rats.
    Li JY; Northover BJ
    Cardiovasc Res; 1992 Nov; 26(11):1116-20. PubMed ID: 1291090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of three class I antiarrhythmic drugs on plateau and pacemaker currents of sheep cardiac Purkinje fibres.
    Coraboeuf E; Deroubaix E; Escande D; Coulombe A
    Cardiovasc Res; 1988 Jun; 22(6):375-84. PubMed ID: 2852055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiologic effects of intravenous carocainide].
    Zannad F; Aliot E; Baille N; Gilgenkrantz JM
    Arch Mal Coeur Vaiss; 1986 Feb; 79(2):236-41. PubMed ID: 3085623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade.
    Pugsley MK; Hayes ES; Saint DA; Walker MJA
    Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways.
    Sethi KK; Jaishankar S; Khalilullah M; Gupta MP
    Br Heart J; 1983 Jun; 49(6):532-43. PubMed ID: 6849716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol.
    Waleffe A; Nzayinambaho K; Rodriguez LM; Dehareng A; Kulbertus HE
    Eur Heart J; 1989 Dec; 10(12):1084-9. PubMed ID: 2606117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia.
    Stiles MK; Sanders P; Disney P; Brooks A; John B; Lau DH; Shashidhar ; Wilson L; Mackenzie L; Young GD
    Am J Cardiol; 2007 Oct; 100(8):1249-53. PubMed ID: 17920366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart.
    Bińkowski BJ; Makowski M; Kubiński P; Lubiński A
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):169-173. PubMed ID: 29623481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.